KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 190 filers reported holding KITE PHARMA INC in Q4 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,805,000 | -52.6% | 23,000 | -72.9% | 1.16% | -45.9% |
| Q4 2016 | $3,812,000 | +36.5% | 85,000 | +70.0% | 2.14% | +23.5% |
| Q3 2016 | $2,793,000 | +458.6% | 50,000 | +400.0% | 1.74% | +952.7% |
| Q2 2016 | $500,000 | -76.8% | 10,000 | -71.4% | 0.16% | -73.4% |
| Q4 2015 | $2,156,000 | +93.7% | 35,000 | +75.0% | 0.62% | +71.1% |
| Q3 2015 | $1,113,000 | – | 20,000 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |